Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Med and Dev Officer
-
Stock Symbol
-
CRNX on Nasdaq
Dana Pizzuti - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
28.5K |
$1.56M |
$54.63 |
Oct 3, 2024 |
Direct |
|
|
Stock option (Right to Buy) |
139K |
|
|
Oct 3, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.